Crossmark

Efficacy and safety of new-generation Bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia/small lymphocytic lymphoma: a systematic review and meta-analysis

Crossref DOI link: https://doi.org/10.1007/s00277-023-05486-x

Published Online: 2023-10-16

Published Print: 2024-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yin, Shuo

Zheng, Xiaohong

Zhang, Weichunbai

Zhao, Hanyun

Zhang, Rong

Li, Wenbin

Chen, Feng
License Information

Text and Data Mining valid from 2023-10-16

Version of Record valid from 2023-10-16
More Information

Article History

Received: 8 July 2023

Accepted: 27 September 2023

First Online: 16 October 2023

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below